Manufacturer's investigation conclusion: the reported event could not be confirmed through this evaluation.The patient remains ongoing on heartmate 3 left ventricular assist system (lvas).No further events have been reported at this time.Although no infection was confirmed, the heartmate 3 lvas instructions for use (ifu) lists infection as an adverse event which may be associated with the use of heartmate 3 lvas.This document cautions the user to avoid pulling on or moving the driveline as it can cause trauma or tissue damage.Both the ifu and patient handbook outline all care instructions for driveline and driveline exit site.The relevant sections of the device history records were reviewed and showed no deviations from manufacturing or quality assurance specifications.The heartmate 3 lvas instructions for use (ifu) is currently available.Section 1, "introduction," lists infection as an adverse event which may be associated with the use of heartmate 3 lvas.Section 6, "patient care management," includes a subsection titled "caring for the driveline exit site" which outlines considerations for driveline care.The heartmate 3 lvas patient handbook is also currently available.Section 4, "living with the heartmate 3," cautions the user to avoid pulling on or moving the driveline as it can cause trauma or tissue damage.This section also provides care instructions for driveline exit site care.No further information was provided.The manufacturer is closing the file on this event.
|